Your browser doesn't support javascript.
loading
Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases.
Prajjwal, Priyadarshi; Marsool, Mohammed Dheyaa Marsool; Asharaf, Shahnaz; Inban, Pugazhendi; Gadam, Srikanth; Yadav, Rukesh; Vora, Neel; Nandwana, Varsha; Marsool, Ali Dheyaa Marsool; Amir, Omniat.
Affiliation
  • Prajjwal P; Department of Neurology Bharati Vidyapeeth University Medical College Pune Pune India.
  • Marsool MDM; Internal Medicine Al-Kindy College of Medicine University of Baghdad Baghdad Iraq.
  • Asharaf S; Internal Medicine, Travancore Medical College Kollam India.
  • Inban P; Internal Medicine, Government Medical College Chennai India.
  • Gadam S; Internal Medicine, Mayo Clinic Rochester New York USA.
  • Yadav R; Internal Medicine, Maharajgunj Medical Campus Tribhuvan University Kathmandu Nepal.
  • Vora N; Internal Medicine, B.J. Medical College Ahmedabad India.
  • Nandwana V; Department of Neurology Virginia Tech Carilion School of Medicine Roanoke Virginia USA.
  • Marsool ADM; Internal Medicine Al-Kindy College of Medicine University of Baghdad Baghdad Iraq.
  • Amir O; Internal Medicine, Al Manhal Academy Khartoum Sudan.
Health Sci Rep ; 6(7): e1422, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37448727
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Health Sci Rep Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Health Sci Rep Year: 2023 Type: Article